Therefore, the changes in HSP levels we observed after 8 weeks of CMS accompanied by depressive-like behavior and reversed by IMI treatment, at least in the group of treatment responders, underlie the mechanism of depression. The gene discussed is HSP90B2P; the disease is depressive disorder.